Medindia

X

/C O R R E C T I O N -- Immucor, Inc./

Thursday, April 1, 2010 Corporate News J E 4
Advertisement

IMMUCOR, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in thousands)

Nine Months Ended

February 28,

February 28,

2010

2009

OPERATING ACTIVITIES:

Net income

$61,096

$56,751

Adjustments to reconcile net income to net cash

provided by operating activities:

Depreciation and amortization

12,233

9,582

Share-based compensation expense

4,164

3,749

Deferred income taxes

(2,376)

1,453

Excess tax benefit from share-based compensation

(209)

(4,347)

Other

735

1,135

Changes in operating assets and liabilities, net of effects from

acquired companies

(20,120)

(14,290)

Cash provided by operating activities

55,523

54,033

INVESTING ACTIVITIES:

Purchases of property and equipment

(5,679)

(6,088)

Acquisition of businesses, net of cash acquired

-

(108,659)

Cash used in investing activities

(5,679)

(114,747)

FINANCING ACTIVITIES:

Repayments of long-term debt and liabilities

-

(213)

Repurchase of common stock

(11,727)

(5,644)

Proceeds from exercise of stock options

269

3,107

Excess tax benefit from share-based compensation

209

4,347

Cash (used in) provided by financing activities

(11,249)

1,597

EFFECT OF EXCHANGE RATES ON CASH AND CASH EQUIVALENTS

566

(2,514)

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

39,161

(61,631)

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

136,461

175,056

CASH AND CASH EQUIVALENTS AT END OF PERIOD

$175,622

$113,425

Supplemental Information - Non-Cash Investing and Financing Activities:

Movement from inventory to property and equipment of instruments placed on rental agreements

$9,444

$5,134

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
New Male Contraception Offered
S
Earnings Conference Call Schedule Change Notificat...